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   This report deals with irp vitrb a＄sessment of sulfac drugs Qn ／．their antibacterial 2ctivity
against 191 strains of bacteria which were isolated from segondary urinqTy traet infeetion during
the recent six months period in our clinic．
   The results obtained were summarized as follows．
   1）Are！ation of inocu！um size with MIC of sulfamethoxypyri皿idine（SMP）was＄urveyed
at the outset． As a result of this survey， it wa’?found”that even 3，200 mcg／ml of SMP could
not inhibit a strain of E． coli from grbWing if 105 c．c．／mJ solu．t，ion． ．．of． ．it was ．g．．＄ed for inoculation，
while the E． coli was fully’@inhibited to grow ・by 25 mcg・／ml if ！0c，c．／ml．・・ A－strain of Klebstella
proved to be much the same as the E． coli，
   2） MICs of SMP’ and sulfadiazine （SD） against the bacteria were deterrnined by plate
dilution methQd using a solution of 106 c、c．／皿l for Gram－pGsitives and a solutien of 105 c．c4ml
for Gram－negatives as inoculum size． Majorities of E． coli， Klebsiella， Morganella， Serratia，
Providencia， S彦aphylo（roccus au7eus and S彦αph二y彦ococcus el）idermidis， and all of Citrobacter and
Enterococcus had MIC more than 1，600 mcg／ml against SMP and SD． Sensitive bacteria having
M工Cless than 50 mcg／ml were found out in o卑正y a few percent of E． coli， Ps．¢udomonas， Morga－
nella and StaPhylocDccus aureus， and in about 40 percent of Proteus mirabilis which was proved
to be most sensitive of all species in our series．
   3） On a base of correlation of the sensitivity distribution of SMP and SD， a cross一．resistance
was estimated to exist closely between SMP and SD against Proteus mirabilis， Pseudomonas．，
Cloaca and StaPhylococcus ePidermidis．
   4） As compared with sensitivity distribution of GM， CB－PC and CEZ against E． coli，’Kleb－
siella， Pseudomonas， StaPhylococcus aureus， StaPhylococcus ePidernzidis and Enterococcus， the sulfa
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1．MICにおよぼす接種菌量の影響
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 Fig． 1． Relation of inoculum size with MIC．
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Table 1． Distribution of susceptibility of bacteria isolated fro皿secondary urinary
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Table 2． Distribution of susceptibility of bacteria isolated from secondary urinary




























































































 まずSMPのMIC（Table 1）をみると， E． coli
37株のうち2株（5．4％）が50mcg／m1のMICを示
したが，他の35株は3，200mcg／ml以上であった．














 つぎにSDのMIC（Table 2）をみると， Et o読
41株のうち2株（4．9％）が200mcg／m1のMICを
示したが，他の39株は1，600mcg／m1以上であった．













100％ （SMP， SD）， Proteus mirabilis 50％， （SMP），
63．6％ （SD）， Pseudomonas 70．8％ （SMP）， 66．7％
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 E． coli， Klebsiella， Pseudomonas， StaPhyleeoccus
aureus， StaPhylococeus ePidermidis， Enterococcus
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 Fig． 5． Curnulative distribution of suscep－
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 Fig． 6． Cumulative distribution of suscep－
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 Fig． 9． Cumulative distribution of sus－
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